14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

SPHS Predictions History

7 years ago
YoungBulls predicted that SPHS for 2017-01-18 is going $2.88 (-0.69%)

Rank:

7 years ago
Mohammad.Hamzeh.1653 predicted that SPHS for 2016-12-08 is going $2.81 (2.55%)

Rank:

7 years ago
JS predicted that SPHS for 2016-09-06 is going $3.36 (8.04%)

7 years ago
JS predicted that SPHS for 2016-08-19 is going $5.92 (4.23%)

7 years ago
Nick predicted that SPHS for 2016-08-19 is going $5.80 (2.11%)

Rank:

7 years ago
StockInvest predicted that SPHS for 2016-08-18 is going $4.21 (-5.39%)

7 years ago
StockInvest predicted that SPHS for 2016-08-16 is going $4.27 (-3.17%)

7 years ago
StockInvest predicted that SPHS for 2016-08-15 is going $4.94 (-2.18%)

7 years ago
JS predicted that SPHS for 2016-08-04 is going $5.33 (0.38%)

7 years ago
StockInvest predicted that SPHS for 2016-07-25 is going $4.72 (-20.67%)

Click to get the best stock tips daily for free!

About Sophiris Bio

Sophiris Bio Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company’s primary product candidate is PRX302, which is in Phase III clinical trial for treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. It has a strategic relationship with Kissei Pha... SPHS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT